Liver Neoplasms, Experimental - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	Liver Neoplasms, Experimental	go back to main search page
Accession:	RDO:0006023	browse the term
Definition:	Experimentally induced tumors of the LIVER.
Synonyms:	exact_synonym:	Experimental Hepatoma; Experimental Hepatomas; Experimental Liver Neoplasm; Morris Hepatoma; Novikoff Hepatoma
	primary_id:	MESH:D008114

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

Liver Neoplasms, Experimental
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb11	ATP-binding cassette, subfamily B (MDR/TAP), member 11			IED				RGD:1598580	RGD
G	Abcb1b	ATP-binding cassette, subfamily B (MDR/TAP), member 1B			IEP	4	21,829,489	21,912,239	RGD:5684351	RGD
G	Adsl	adenylosuccinate lyase			IEP	7	119,223,582	119,248,151	RGD:1598766	RGD
G	Agps	alkylglycerone phosphate synthase			IED				RGD:1598794	RGD
G	Arrb2	arrestin, beta 2			IEP	10	57,244,071	57,284,166	RGD:5509890	RGD
G	Birc5	baculoviral IAP repeat-containing 5			IEP				RGD:2293125	RGD
G	Cad	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			IEP	6	25,272,416	25,296,266	RGD:5132586	RGD
G	Ccnb1	cyclin B1			IEP	2	31,574,600	31,581,784	RGD:2315991	RGD
G	Ccnd1	cyclin D1			IEP	1	205,357,235	205,366,757	RGD:2289139	RGD
G	Cd40lg	CD40 ligand			ISS	X	141,925,019	141,937,183	RGD:5491179	RGD
G	Cps1	carbamoyl-phosphate synthetase 1		Severity	IEP	9	65,907,211	66,017,942	RGD:2303406	RGD
G	Dhodh	dihydroorotate dehydrogenase (quinone)			IEP	19	39,463,111	39,477,184	RGD:5132618	RGD
G	Dtymk	deoxythymidylate kinase (thymidylate kinase)			IEP	9	93,065,333	93,074,168	RGD:5133686	RGD
G	Gstp1	glutathione S-transferase pi 1			IEP	1	206,627,398	206,629,866	RGD:2317823	RGD
G	H19	H19, imprinted maternally expressed transcript (non-protein coding)			IED	1	202,822,925	202,825,601	RGD:1342455	RGD
G	Hat1	histone acetyltransferase 1			IEP	3	53,696,664	53,744,333	RGD:2316578	RGD
G	Htr2c	5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled			IEP	X	31,012,921	31,244,127	RGD:1624998	RGD
G	Igf2r	insulin-like growth factor 2 receptor			IAGP	1	42,253,273	42,341,646	RGD:2311623	RGD
G	Igf2r	insulin-like growth factor 2 receptor			IAGP	1	42,253,273	42,341,646	RGD:2311630	RGD
G	Map2k1	mitogen activated protein kinase kinase 1			IEP	8	68,379,074	68,451,554	RGD:2306052	RGD
G	Mmp2	matrix metallopeptidase 2			IEP	19	15,246,036	15,275,061	RGD:2325736	RGD
G	Mmp2	matrix metallopeptidase 2			IEP	19	15,246,036	15,275,061	RGD:2325734	RGD
G	Mmp9	matrix metallopeptidase 9			IEP	3	155,985,473	155,993,433	RGD:2325734	RGD
G	Mmp9	matrix metallopeptidase 9			IEP	3	155,985,473	155,993,433	RGD:2325736	RGD
G	Nos2	nitric oxide synthase 2, inducible			IEP	10	65,036,884	65,072,453	RGD:2325277	RGD
G	Notch1	notch 1			IEP	3	4,631,797	4,677,640	RGD:2325310	RGD
G	Pemt	phosphatidylethanolamine N-methyltransferase			IEP				RGD:1642378	RGD
G	Rad51	RAD51 homolog (S. cerevisiae)			IEP	3	105,625,265	105,650,392	RGD:2292638	RGD
G	Rrm1	ribonucleotide reductase M1			IEP				RGD:2316863	RGD
G	Rxra	retinoid X receptor alpha			IEP	3	6,605,782	6,689,224	RGD:1643105	RGD
G	Serpina1	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1			IEP	6	127,998,617	128,021,719	RGD:1626391	RGD
G	Tgfa	transforming growth factor alpha			IEP	4	120,355,649	120,437,772	RGD:2317490	RGD
G	Vim	vimentin			IED	17	87,847,280	87,855,763	RGD:6480440	RGD
Q	Hcar1	Hepatocarcinoma resistance QTL 1			IED	10	6,172,805	36,254,741	RGD:619598	RGD
Q	Hcar10	Hepatocarcinoma resistance QTL 10			IED	8	43,313,902	87,122,960	RGD:629566	RGD
Q	Hcar11	Hepatocarcinoma resistance QTL 11			IED	6	41,300,997	115,238,799	RGD:629566	RGD
Q	Hcar12	Hepatocarcinoma resistance QTL 12			IED	3	25,775,548	118,863,223	RGD:629566	RGD
Q	Hcar13	Hepatocarcinoma resistance QTL 13			IED	4	1	29,414,068	RGD:737884	RGD
Q	Hcar14	Hepatocarcinoma resistance QTL 14			IED	18	53,847,682	86,863,412	RGD:737884	RGD
Q	Hcar15	Hepatocarcinoma resistance QTL 15			IED	1	156,124,624	247,322,277	RGD:1358145	RGD
Q	Hcar2	Hepatocarcinoma resistance QTL 2			IED	4	78,035,196	135,074,488	RGD:619598	RGD
Q	Hcar3	Hepatocarcinoma resistance QTL 3			IED	8	57,308,572	103,684,785	RGD:619598	RGD
Q	Hcar4	Hepatocarcinoma resistance QTL 4			IED	1	198,396,580	220,639,653	RGD:619609	RGD
Q	Hcar5	Hepatocarcinoma resistance QTL 5			IED	1	220,639,539	232,579,992	RGD:619609	RGD
Q	Hcar6	Hepatocarcinoma resistance QTL 6			IED	1	224,822,211	267,910,886	RGD:619609	RGD
Q	Hcar7	Hepatocarcinoma resistance QTL 7			IED	4	58,550,170	93,498,821	RGD:619609	RGD
Q	Hcar8	Hepatocarcinoma resistance QTL 8			IED				RGD:619609	RGD
Q	Hcar9	Hepatocarcinoma resistance QTL 9			IED	4	106,554,769	171,204,531	RGD:629566	RGD
Q	Hcas1	Hepatocarcinoma susceptibility QTL 1			IED	7	96,649,133	137,404,381	RGD:619598	RGD
Q	Hcas2	Hepatocarcinoma susceptibility QTL 2			IED	1	6,253,946	116,153,262	RGD:619598	RGD
Q	Hcas3	Hepatocarcinoma susceptibility QTL 3			IED	1	146,971,846	228,781,113	RGD:629566	RGD
Q	Hcas4	Hepatocarcinoma susceptibility QTL 4			IED	16	4,304,396	50,266,190	RGD:629566	RGD
Q	Hcas5	Hepatocarcinoma susceptibility QTL 5			IED	1	180,678,929	265,343,617	RGD:737884	RGD
Q	Hcas6	Hepatocarcinoma susceptibility QTL 6			IED	14	41,608,939	89,192,873	RGD:737884	RGD
Q	Hcas7	Hepatocarcinoma susceptibility QTL 7			IED	15	2,306,220	43,057,384	RGD:737884	RGD
Q	Hcas8	Hepatocarcinoma susceptibility QTL 8			IED	16	1	24,132,402	RGD:1599590	RGD
S	ACI/N	A X C 9935, Irish		Model	TAS				RGD:1004	RGD
S	DRH/Seac			Resistance	TAS				RGD:625382	RGD

Term paths to the root

Path 1
Term	Annotations
Diseases	30477
Neoplasms	5210
Neoplasms, Experimental	308
Liver Neoplasms, Experimental	58
Path 2
Term	Annotations
Diseases	30477
Neoplasms	5210
Neoplasms by Site	3798
Digestive System Neoplasms	944
Liver Neoplasms	170
Liver Neoplasms, Experimental	58